FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used for prediction of ventricular tachyarrhythmia (VTA). Patient is examined for the following: a diagnosis of atrial fibrillation (AF) at the moment of implantation (X1); presence of atrial flutter in past history and at implantation of device (X2); presence of persistent atrial fibrillation at programming visit of implanted device (X3); reported paroxysmal AF by implanted device data or directly at patient's visit (X4), value of heart rate (X5, beat/min) at visit of patient. Further, the logistic function is calculated to estimate the true VTA detection risk by the claimed formula. From obtained values of logistic function ψ risk of true VTA is evaluated. If the value ψ less than -2.94, risk of true VTA detection is less than 5 %. If the value ψ from -2.94 to 0, risk of true GTA detection from 5 to 50 %. If the value ψ 0–2.94, risk of true VTA detection is 50–95 %. If the value ψ more than 2.94, risk of true VTA detection more than 95 %.
EFFECT: method enables to predict the probability of detecting true VTA in patients with implanted devices, reducing the risk of applying unmotivated electrotherapy in the implanted electronic device (ICD) as a result of supraventricular tachyarrhythmias by evaluating the complex of the most significant indicators.
1 cl, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF REMOTE UNFAVORABLE OUTCOMES IN PATIENTS WITH HEART FAILURE AND IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2819279C1 |
METHOD FOR PREDICTING RISK OF DEVELOPING NONARRHYTHMIC DEATH IN FOUR-YEAR FOLLOW-UP PERIOD IN PATIENTS WITH HEART FAILURE WITH REDUCED LEFT VENTRICULAR FRACTION AND AN IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2820923C1 |
METHOD OF PREDICTING RISK OF DEVELOPING ACUTE DECOMPENSATION OF HEART FAILURE IN PATIENTS WITH LOW LEFT VENTRICULAR EJECTION FRACTION AND IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2809775C1 |
METHOD OF PREDICTING RISK OF DEVELOPING FUNCTIONAL CLASS III CHRONIC HEART FAILURE IN PATIENTS WITH VENTRICULAR TACHYARRHYTHMIAS AND IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2807272C1 |
METHOD FOR DETECTING RHYTHM DISTURBANCES AND CONDUCTION IN PATIENTS WITH EPILEPSY BY USING AN IMPLANTED SUBCUTANEOUS ECG LOOP REGISTER | 2017 |
|
RU2665019C1 |
METHOD FOR STENT THROMBOSIS PREDICTION IN THE PATIENTS WITH ACUTE CORONARY SYNDROME AFTER A PERCUTANEOUS CORONARY INTERVENTION WITH A BACKGROUND OF DOUBLE ANTIPLATELET THERAPY | 2018 |
|
RU2690892C1 |
METHOD FOR PREDICTION OF DEVELOPMENT OF LIFE-THREATENING AURICULAR ARRYTHMIA IN PATIENTS WITH HYPERTENSION DISEASE | 2016 |
|
RU2634246C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING VENTRICULAR TACHYCARDIA IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND LEFT VENTRICULAR EJECTION FRACTION LESS THAN 35 % | 2021 |
|
RU2770267C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING LEFT VENTRICULAR GLOBAL LONGITUDINAL DEFORMITY AFTER COVID-19 PNEUMONIA IN INDIVIDUALS WITHOUT PULMONARY EMBOLISM, PERIPHERAL THROMBOSIS, CORONARY HEART DISEASE, AND ATRIAL FIBRILLATION | 2022 |
|
RU2782299C1 |
METHOD OF DIAGNOSING PAROXYSMAL TACHYCARDIA | 2009 |
|
RU2411902C1 |
Authors
Dates
2019-11-22—Published
2018-09-07—Filed